Reverto bio

Generative-AI and Biology to Reprogram Cells

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2025 by Rami Kasterstein, Reverto bio operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on its initial development.

Business overview

Reverto bio leverages Generative-AI and Biology to develop solutions for reprogramming cells, aiming to reverse biological conditions. The company's core technology integrates artificial intelligence, specifically Generative AI, with biological sciences to create innovative approaches in the Health Tech & Life Sciences sector. It operates within the B2B business model, targeting various industries with its R&D-stage products.

Company Intelligence Q&A

When was Reverto bio founded?
Reverto bio was founded in January 2025.
Who is the founder of Reverto bio?
Rami Kasterstein is the founder of Reverto bio.
What is Reverto bio's primary focus?
Reverto bio focuses on combining Generative-AI and Biology to reprogram cells and address biological conditions.
What is the current employee size of Reverto bio?
Reverto bio currently has 1–10 employees.
What is Reverto bio's primary sector?
Reverto bio operates in the Health Tech & Life Sciences sector.